Qiagen inks deal to buy Corbett

Qiagen is buying Corbett Life Science for $70 million down in cash and stock and another $65 million in milestones. Corbett manufactures and distributes life sciences instrumentation. Corbett is best known for the first rotary, real-time PCR cycler system--the Rotor-Gene. Report